21 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Sorrento Therapeutics, Inc. SRNE shares moved upwards by 58.4% to $5.40 during Friday's pre-market session.
• Seelos Therapeutics, Inc. SEEL shares rose 26.2% to $1.83. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $2.00.
• Aclaris Therapeutics, Inc. ACRS stock increased by 19.4% to $2.22. According to the most recent rating by SVB Leerink, on October 23, the current rating is at Outperform.
• Helius Medical Tech, Inc. HSDT shares moved upwards by 14.1% to $1.05.
• Diffusion Pharmaceuticals, Inc. DFFN shares increased by 5.5% to $0.48. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
• Titan Pharmaceuticals, Inc. TTNP stock increased by 4.0% to $0.31. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• Aquestive Therapeutics, Inc. AQST shares moved upwards by 3.3% to $6.60. The most recent rating by Wedbush, on December 17, is at Outperform, with a price target of $34.00.
• Ocugen, Inc. OCGN shares surged 3.1% to $0.69. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
• Onconova Therapeutics, Inc. ONTX stock moved upwards by 2.6% to $0.47.
• Advaxis, Inc. ADXS shares moved upwards by 2.6% to $1.19.
• Dermira, Inc. DERM shares increased by 2.4% to $18.78.
• DBV Technologies, Inc. DBVT shares moved upwards by 2.2% to $13.19. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
• Trillium Therapeutics, Inc. TRIL shares moved upwards by 2.1% to $2.95.
• Qiagen, Inc. QGEN stock surged 1.1% to $35.07. The most recent rating by Wells Fargo, on January 08, is at Equal-Weight, with a price target of $36.00.
• Achieve Life Sciences, Inc. ACHV shares moved upwards by 1.0% to $0.57.

Losers

• Portola Pharmaceuticals, Inc. PTLA stock fell 39.9% to $14.88 during Friday's pre-market session. The most recent rating by Oppenheimer, on January 10, is at Perform, with a price target of $17.00.
• Aurora Cannabis, Inc. ACB stock decreased by 7.8% to $1.71. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
• Applied Genetic Tech, Inc. AGTC shares fell 7.8% to $8.55.
• Melinta Therapeutics, Inc. MLNT shares declined 4.9% to $0.50.
• Amarin Corp, Inc. AMRN shares fell 2.2% to $19.55. The most recent rating by JP Morgan, on January 06, is at Neutral, with a price target of $22.00.
• Mirati Therapeutics, Inc. MRTX stock decreased by 1.1% to $97.40.